https://scholars.lib.ntu.edu.tw/handle/123456789/111976
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 陳建仁 | en |
dc.contributor | 臺灣大學:流行病學研究所 | zh_TW |
dc.contributor.author | 盧彥安 | zh |
dc.contributor.author | Lu, Yan-An | en |
dc.creator | 盧彥安 | zh |
dc.creator | Lu, Yan-An | en |
dc.date | 2005 | en |
dc.date.accessioned | 2007-11-27T02:49:20Z | - |
dc.date.accessioned | 2018-06-29T17:44:50Z | - |
dc.date.available | 2007-11-27T02:49:20Z | - |
dc.date.available | 2018-06-29T17:44:50Z | - |
dc.date.issued | 2005 | - |
dc.identifier | en-US | en |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/56161 | - |
dc.description.abstract | 目的: 本研究探討DNA修補相關基因的基因多形性與台灣女性肺腺癌危險性的獨立作用與交互作用,包括:hOGG1 Ser326Cys、XRCC1 Arg194Thr、XRCC1 Arg280His、XRCC1 Arg399Gln、Lig1 C170A、XPD Lys751Gln、hMLH1 G-93A、XRCC3 Thr241Met、p53 Arg72Pro與p21 Ser31Arg共10個多形性。 方法: 本研究為一病例對照研究,納入來自臺大醫院的女性肺腺癌病例共180名與臺大健檢中心的健康對照350名。基因多形性的鑑定利用聚合酵素連鎖反應以及Taqman即時聚合酵素連鎖反應為基礎的方式分析。各基因多形性的危險對比值和95%信賴區間估計以非條件式羅吉斯迴歸模式進行。 結果: 調整年齡、教育年數、吸煙與二手煙暴露、油煙暴露等因子後,XRCC1 399 Gln/Gln基因型相對於Arg/Arg或Arg/Gln基因型有2.21倍的危險性 (95% CI=1.2~4.2);XPD 751 Gln/Gln基因型相對於Lys/Lys或Lys/Gln基因型有7.98倍的危險性 (95% CI=1.6~41.1);p21 codon 31 Ser/Ser或Ser/Arg基因型相對危險性為Arg/Arg基因型的1.77倍(95% CI=1.1~3.0)。標記間交互作用分析則發現各標記的作用主要為獨立存在。基因多形性與環境暴露間的交互作用,也未具統計上的顯著性。 結論: 本研究發現DNA修補基因XRCC1 Arg399Gln、XPD Lys751Gln、p21 Ser31Arg多形性與肺腺癌的發生有關。 | zh_TW |
dc.description.abstract | Background DNA damage is an unavoidable result by exposing to intrinsic or extrinsic factors. DNA repair is an essential mechanism for maintaining integrity and accuracy of DNA, reduced DNA repair capacity may increase the susceptibility to cancer. We examined association among ten polymorphisms of DNA repair-related genes (hOGG1 Ser326Cys, XRCC1 Arg194Thr, XRCC1 Arg280His, XRCC1 Arg399Gln, Lig1 C170A, XPD Lys751Gln, hMLH1 G-93A, XRCC3 Thr241Met, p53 Arg72Pro, and p21 Ser31Arg) and lung adenocarcinoma risk among Taiwanese female. Methods A total of 180 female patients with lung adenocarcinoma and 350 healthy hospital control subject recruited in northern Taiwan from July 1997 until July 2000 provided DNA samples for genotype analysis. Genetic polymorphisms were analyzed by PCR-RFLP and Taqman assays. Unconditional multivariate logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Results After adjusted for age, school year, tobacco exposure, and cooking fume exposure, the OR of developing adenocarcinoma was 2.21 (95% CI= 1.2~4.2) for XRCC1 399 Gln/Gln genotype (compared with other genotypes), 7.98 (95% CI=1.6~41.1) for XPD 751 Gln/Gln genotype (compared with other genotypes), and 1.77 (95% CI= 1.1~3.0) for p21 codon 31 Ser/Ser or Ser/Arg genotypes (compared with Arg/Arg genotype). Interactions between markers were not statistically significant, and so did interactions between markers and environmental exposures. Conclusion Our results suggests that the homozygous Gln alleles in codon 399 of the XRCC1 gene, homozygous Gln alleles in codon 751 of the XPD gene, and homozygous Ser alleles in codon 31 of the p21 gene might contribute to lung adenocarcinoma risk. | en |
dc.description.tableofcontents | CHAPTER 1. INTRODUCTION 1 1.1 Risk Factors 1 Cigarette Smoking 1 Passive Smoking 3 Domestic Cooking Fumes 3 Environmental Pollution 4 Previous Respiratory Disease 5 1.2 DNA Repair Mechanisms and polymorphisms 6 Base Excision Repair (BER) 8 hOGG1 8 XRCC1 10 Ligase1 10 Nucleotide Excision Repair (NER) 13 XPD 13 Mismatch Repair (MMR) 13 hMLH1 13 Double-strand-break Repair 16 XRCC3 16 Cell Cycle Control and Repair Regulation 18 p53 18 p21 18 CHAPTER 2. SUBJECTS AND METHODS 21 2.1 Case and Control Recruitment 21 2.2 Genotyping of DNA Repair Genes 22 2.3 Statistical Analysis 25 CHAPTER 3. RESULTS 26 3.1 Demographic Characteristics of Study Subjects 26 3.2 Ambient Air Pollution Exposure of Study Subjects 27 3.3 SNPs of DNA repair polymorphisms 29 3.4 Marker-Marker Interaction 33 3.5 Genetic Marker and Environmental Factor Interaction 37 CHAPTER 4. DISSCUSSION 39 References 45 Content of Tables Table 1.1 Studies on hOGG1 326 polymorphism and lung cancer risk 9 Table 1.2 Studies on XRCC1 polymorphisms and lung cancer risk 11 Table 1.3 Studies on Lig1 170 polymorphism and lung cancer risk 12 Table 1.4 Studies on XPD 751 polymorphism and lung cancer risk 14 Table 1.5 Studies on hMLH1 G-93A polymorphism and lung cancer risk 15 Table 1.6 Studies on XRCC3 241 polymorphism and lung cancer risk 17 Table 1.7 Studies on p53 72 polymorphism and lung cancer risk 19 Table 1.8 Studies on p21 31 polymorphism and lung cancer risk 19 Table 2.1 Sequence of Primer and Probe sets for Taqman technique 24 Table 3.1 Demographic characteristics of study subjects 26 Table 3.2 ORs and 95% CI of ambient air pollution exposure 28 Table 3.3 ORs and 95% CI of SNPs of DNA repair polymorphisms 30 Table 3.4 p-values based on chi-square test for marker-marker independence 34 Table 3.5 p-values based on regression model for marker-marker interaction term 34 Table 3.6 Gene-gene interaction between XRCC3 and p53 polymorphism 35 Table 3.7 ORs and 95% CI of combined SNPs of repair polymorphisms 36 Table 3.8 Tobacco exposure-stratified ORs of combined SNPs 38 Table 3.9 Cooking fume exposure-stratified ORs of combined SNPs 38 Table 3.10 Environmental exposure-stratified ORs of combined SNPs 38 | en |
dc.language | en-US | en |
dc.language.iso | en_US | - |
dc.subject | 女性肺腺癌 | en |
dc.subject | DNA修補 | en |
dc.subject | 多形性 | en |
dc.subject | female lung adenocarcinoma | en |
dc.subject | DNA repair | en |
dc.subject | polymorphism | en |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | 台灣北部地區女性肺腺癌DNA修補相關基因多形性之流行病學研究 | zh_TW |
dc.title | Polymorphisms in DNA Repair Related Genes and Risk of Female Lung Adenocarcinoma in Northern Taiwan | en |
dc.type | thesis | en |
dc.relation.reference | 1. Wolpaw, D.R., Early detection in lung cancer. Case finding and screening. Med Clin North Am, 1996. 80(1): p. 63-82. 2. Biesalski, H.K., et al., European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel. CA Cancer J Clin, 1998. 48(3): p. 167-176. 3. Ruano-Ravina, A., A. Figueiras, and J.M. Barros-Dios, Lung cancer and related risk factors: an update of the literature. Public Health, 2003. 117(3): p. 149-156. 4. Wen Cheng, Y. and H. Lee, Environmental exposure and lung cancer among nonsmokers: an example of Taiwanese female lung cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 2003. 21(1): p. 1-28. 5. Hecht, S.S., Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst, 1999. 91(14): p. 1194-210. 6. Hoffmann, D., M.V. Djordjevic, and I. Hoffmann, The changing cigarette. Prev Med, 1997. 26(4): p. 427-34. 7. Denissenko, M.F., et al., Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 1996. 274(5286): p. 430-2. 8. Takagi, Y., et al., p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking. Br J Cancer, 1998. 77(10): p. 1568-72. 9. Gealy, R., et al., Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomarkers Prev, 1999. 8(4 Pt 1): p. 297-302. 10. Lubin, J.H. and W.J. Blot, Assessment of lung cancer risk factors by histologic category. J Natl Cancer Inst, 1984. 73(2): p. 383-9. 11. Wu, A.H., et al., Smoking and other risk factors for lung cancer in women. J Natl Cancer Inst, 1985. 74(4): p. 747-51. 12. Higgins, I.T. and E.L. Wynder, Reduction in risk of lung cancer among ex-smokers with particular reference to histologic type. Cancer, 1988. 62(11): p. 2397-401. 13. Morabia, A. and E.L. Wynder, Cigarette smoking and lung cancer cell types. Cancer, 1991. 68(9): p. 2074-8. 14. Wynder, E.L. and D. Hoffmann, Smoking and lung cancer: scientific challenges and opportunities. Cancer Res, 1994. 54(20): p. 5284-95. 15. Charloux, A., et al., The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol, 1997. 26(1): p. 14-23. 16. Ger, L.P., et al., [Risk factors of lung cancer]. J Formos Med Assoc, 1992. 91 Suppl 3: p. S222-31. 17. ART, Alcohol Consumption Investigation in Taiwan Area. 1993, Taipei, Taiwan: Bureau of Tobacco and Alcohol Monopoly. Taiwan Provincial Government. 18. Pezzotto, S.M., et al., Variation in smoking-related lung cancer risk factors by cell type among men in Argentina: a case-control study. Cancer Causes Control, 1993. 4(3): p. 231-7. 19. Ellard, G.A., F. de Waard, and J.M. Kemmeren, Urinary nicotine metabolite excretion and lung cancer risk in a female cohort. Br J Cancer, 1995. 72(3): p. 788-91. 20. Siemiatycki, J., et al., Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study. Int J Epidemiol, 1995. 24(3): p. 504-14. 21. de Waard, F., et al., Urinary cotinine and lung cancer risk in a female cohort. Br J Cancer, 1995. 72(3): p. 784-7. 22. Engeland, A., et al., The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women. Cancer Causes Control, 1996. 7(3): p. 366-76. 23. Agency, E.P., Respiratory health effects of passive smoking: lung cancer and other disorders, EPA/600/6-90/006F. 1992, Washington, DC: EPA Office of Research and development. 24. Brownson, R.C., et al., Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol Rev, 1998. 20(2): p. 218-36. 25. Fontham, E.T., et al., Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. Jama, 1994. 271(22): p. 1752-9. 26. Wu, M.T., et al., Lifetime exposure to environmental tobacco smoke and cervical intraepithelial neoplasms among nonsmoking Taiwanese women. Arch Environ Health, 2003. 58(6): p. 353-9. 27. Lee, C.H., et al., Lifetime environmental exposure to tobacco smoke and primary lung cancer of non-smoking Taiwanese women. Int J Epidemiol, 2000. 29(2): p. 224-31. 28. Lam, T.H., et al., Smoking, passive smoking and histological types in lung cancer in Hong Kong Chinese women. Br J Cancer, 1987. 56(5): p. 673-8. 29. Ko, Y.C., et al., Chinese food cooking and lung cancer in women nonsmokers. Am J Epidemiol, 2000. 151(2): p. 140-7. 30. Zhou, B.S., et al., Indoor air pollution and pulmonary adenocarcinoma among females: a case-control study in Shenyang, China. Oncol Rep, 2000. 7(6): p. 1253-9. 31. Chiang, T.A., et al., Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan. Mutat Res, 1997. 381(2): p. 157-61. 32. Lin, S.Y., et al., Protection by quercetin against cooking oil fumes-induced DNA damage in human lung adenocarcinoma CL-3 cells: role of COX-2. Nutr Cancer, 2002. 44(1): p. 95-101. 33. Zienolddiny, S., D. Ryberg, and A. Haugen, Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines. Carcinogenesis, 2000. 21(8): p. 1521-6. 34. Takabe, W., et al., Oxidative stress promotes the development of transformation: involvement of a potent mutagenic lipid peroxidation product, acrolein. Carcinogenesis, 2001. 22(6): p. 935-41. 35. 葛應欽 and 李建宏, 不吸菸婦女肺癌研究. 生命科學簡訊. 13(4): p. 12-5. 36. Ko, Y.C., et al., Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol, 1997. 26(1): p. 24-31. 37. Lai, C.H., et al., Exposure to traffic exhausts and oxidative DNA damage. Occup Environ Med, 2005. 62(4): p. 216-22. 38. Katsouyanni, K. and G. Pershagen, Ambient air pollution exposure and cancer. Cancer Causes Control, 1997. 8(3): p. 284-91. 39. Minna, J.D., Genetic events in the pathogenesis of lung cancer. Chest, 1989. 96(1 Suppl): p. 17S-23S. 40. Storey, A., et al., Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 1998. 393(6682): p. 229-34. 41. Cheng, Y.W., et al., The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res, 2001. 61(7): p. 2799-803. 42. Vogelstein, B. and K.W. Kinzler, The multistep nature of cancer. Trends Genet, 1993. 9(4): p. 138-41. 43. Mitra, S., et al., Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage. Environmental and Molecular Mutagenesis, 2001. 38(2-3): p. 180-90. 44. Izumi, T., et al., Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage. Toxicology, 2003. 193(1-2): p. 43-65. 45. Mitchell, J.R., J.H. Hoeijmakers, and L.J. Niedernhofer, Divide and conquer: nucleotide excision repair battles cancer and ageing. Current Opinion in Cell Biology, 2003. 15(2): p. 232-240. 46. Bellacosa, A., Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death and Differentiation, 2001. 8: p. 1076-92. 47. Valerie, K. and L.F. Povirk, Regulation and mechanisms of mammalian double-strand break repair. Oncogene, 2003. 22(37): p. 5792-812. 48. Shibutani, S., M. Takeshita, and A.P. Grollman, Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature, 1991. 349(6308): p. 431-4. 49. Maki, H. and M. Sekiguchi, MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature, 1992. 355(6357): p. 273-5. 50. Tajiri, T., H. Maki, and M. Sekiguchi, Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli. Mutat Res, 1995. 336(3): p. 257-67. 51. Yamane, A., et al., Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo. Carcinogenesis, 2003. 24(6): p. 1031-7. 52. Sugimura, H., et al., hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 1999. 8(8): p. 669-74. 53. Wikman, H., et al., hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population. Int J Cancer, 2000. 88(6): p. 932-7. 54. Le Marchand, L., et al., Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev, 2002. 11(4): p. 409-12. 55. Ito, H., et al., A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol, 2002. 12(3): p. 258-65. 56. Park, J., et al., The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics, 2004. 14(2): p. 103-9. 57. Weiss, J.M., et al., Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog, 2005. 42(3): p. 127-41. 58. Thompson, L.H. and M.G. West, XRCC1 keeps DNA from getting stranded. Mutat Res, 2000. 459(1): p. 1-18. 59. Zdzienicka, M.Z., et al., A Chinese hamster ovary cell mutant (EM-C11) with sensitivity to simple alkylating agents and a very high level of sister chromatid exchanges. Mutagenesis, 1992. 7(4): p. 265-9. 60. Vodicka, P., et al., Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis, 2004. 25(5): p. 757-763. 61. David-Beabes, G.L. and S.J. London, Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer, 2001. 34(3): p. 333-9. 62. Butkiewicz, D., et al., Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis, 2001. 22(4): p. 593-597. 63. Ratnasinghe, D., et al., Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 2001. 10(2): p. 119-23. 64. Divine, K.K., et al., The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res, 2001. 461(4): p. 273-8. 65. Chen, S., et al., DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis, 2002. 23(8): p. 1321-1325. 66. Park, J.Y., et al., Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev, 2002. 11(1): p. 23-7. 67. Misra, R.R., et al., Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer amongmale smokers in Finland. Cancer Letters, 2003. 191(2): p. 171-178. 68. Zhou, W., et al., Polymorphisms in the DNA Repair Genes XRCC1 and ERCC2, Smoking, and Lung Cancer Risk. Cancer Epidemiol Biomarkers Prev, 2003. 12(4): p. 359-365. 69. Ito, H., et al., Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis, 2004. 25(8): p. 1395-401. 70. Harms, C., et al., Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen, 2004. 44(1): p. 74-82. 71. Popanda, O., et al., Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis, 2004: p. bgh264. 72. Shen, H., et al., Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. Lung Cancer, 2002. 36(3): p. 243-7. 73. Weber, C.A., et al., Molecular cloning and biological characterization of a human gene, ERCC2, that corrects the nucleotide excision repair defect in CHO UV5 cells. Mol Cell Biol, 1988. 8(3): p. 1137-46. 74. Benhamou, S. and A. Sarasin, ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis, 2002. 17(6): p. 463-469. 75. Liang, G., et al., Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. International Journal of Cancer, 2003. 105(5): p. 669-73. 76. Hu, Z., et al., DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer, 2004. 46(1): p. 1-10. 77. Spitz, M.R., et al., Modulation of Nucleotide Excision Repair Capacity by XPD Polymorphisms in Lung Cancer Patients. Cancer Res, 2001. 61(4): p. 1354-1357. 78. Hou, S.-M., et al., The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis, 2002. 23(4): p. 599-603. 79. Park, J.Y., et al., Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer, 2002. 36(1): p. 15-16. 80. Xing, D., et al., Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer, 2002. 38(2): p. 123-129. 81. Bronner, C.E., et al., Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 1994. 368(6468): p. 258-61. 82. Ito, E., et al., A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun, 1999. 256(3): p. 488-94. 83. Park, S.H., et al., -93G-->A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer, 2004. 112(4): p. 678-82. 84. Zdzienicka, M.Z., Mammalian mutants defective in the response to ionizing radiation-induced DNA damage. Mutat Res, 1995. 336(3): p. 203-13. 85. Au, W.W., S.A. Salama, and C.H. Sierra-Torres, Functional Characterization of Polymorphisms in DNA Repair Genes Using Cytogenetic Challenge Assays. Environmental Health Perspectives, 2003. 111(15): p. 1843-50. 86. Smith, M.L. and Y.R. Seo, p53 regulation of DNA excision repair pathways. Mutagenesis, 2002. 17(2): p. 149-56. 87. Adimoolam, S. and J.M. Ford, p53 and regulation of DNA damage recognition during nucleotide excision repair. DNA Repair (Amst), 2003. 2(9): p. 947-54. 88. Bertrand, P., Y. Saintigny, and B.S. Lopez, p53's double life: transactivation-independent repression of homologous recombination. Trends Genet, 2004. 20(6): p. 235-43. 89. Wang, Y.C., et al., p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res, 1999. 5(1): p. 129-34. 90. Fan, R., et al., The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 2000. 9(10): p. 1037-42. 91. Liu, G., et al., Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res, 2001. 61(24): p. 8718-22. 92. Irarrazabal, C.E., et al., Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol Lett, 2003. 144(1): p. 69-76. 93. Dumont, P., et al., The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet, 2003. 33(3): p. 357-65. 94. Smith, M.L., et al., p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol, 2000. 20(10): p. 3705-14. 95. Bunz, F., et al., Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science, 1998. 282(5393): p. 1497-501. 96. Zakut, R. and D. Givol, The tumor suppression function of p21Waf is contained in its N-terminal half ('half-WAF'). Oncogene, 1995. 11(2): p. 393-5. 97. Adimoolam, S., C.X. Lin, and J.M. Ford, The p53-regulated cyclin-dependent kinase inhibitor, p21 (cip1, waf1, sdi1), is not required for global genomic and transcription-coupled nucleotide excision repair of UV-induced DNA photoproducts. J Biol Chem, 2001. 276(28): p. 25813-22. 98. Fan, S., et al., Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene, 1997. 14(18): p. 2127-36. 99. Sheikh, M.S., et al., Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene, 1997. 14(15): p. 1875-82. 100. Stivala, L.A., et al., p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitment of PCNA to DNA repair sites. Oncogene, 2001. 20(5): p. 563-70. 101. Sjalander, A., et al., Association between the p21 codon 31 A1 (arg) allele and lung cancer. Hum Hered, 1996. 46(4): p. 221-5. 102. Shih, C.M., et al., Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. Jpn J Cancer Res, 2000. 91(1): p. 9-15. 103. Su, L., et al., No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 2003. 12(2): p. 174-5. 104. Sun, Y., et al., No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol Biomarkers Prev, 1995. 4(3): p. 261-7. 105. Terry, L.A., et al., Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines. Mol Carcinog, 1996. 16(4): p. 221-8. 106. Wong, M.P., et al., Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance. Cancer Res, 2002. 62(15): p. 4464-8. 107. Su, L., et al., P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer, 2003. 40(3): p. 259-266. 108. Seoane, J., H.V. Le, and J. Massague, Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature, 2002. 419(6908): p. 729-34. 109. Morimoto, L.M., E. White, and P.A. Newcomb, Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol, 2003. 158(3): p. 259-63. | zh_TW |
item.openairecristype | http://purl.org/coar/resource_type/c_46ec | - |
item.openairetype | thesis | - |
item.languageiso639-1 | en_US | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
顯示於: | 流行病學與預防醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。